110 related articles for article (PubMed ID: 3150321)
1. Changes in the qualitative and quantitative secretion of luteinizing hormone (LH) following orchidectomy in man.
Tsatsoulis A; Shalet SM; Robertson WR
Clin Endocrinol (Oxf); 1988 Aug; 29(2):189-94. PubMed ID: 3150321
[TBL] [Abstract][Full Text] [Related]
2. The ratios of serum bioactive/immunoreactive luteinizing hormone and follicle-stimulating hormone in various clinical conditions with increased and decreased gonadotropin secretion: reevaluation by a highly sensitive immunometric assay.
Jaakkola T; Ding YQ; Kellokumpu-Lehtinen P; Valavaara R; Martikainen H; Tapanainen J; Rönnberg L; Huhtaniemi I
J Clin Endocrinol Metab; 1990 Jun; 70(6):1496-505. PubMed ID: 2140831
[TBL] [Abstract][Full Text] [Related]
3. Effects of oestrogen treatment on serum gonadotrophin bioactivity, immunoreactivity and isohormone distribution, and on immunoreactive inhibin levels, in prostatic cancer patients.
Matikainen T; Haavisto AM; Permi J; de Kretser D; Huhtaniemi I
Clin Endocrinol (Oxf); 1994 Jun; 40(6):743-50. PubMed ID: 8033364
[TBL] [Abstract][Full Text] [Related]
4. The pulsatile secretion of bioactive luteinising hormone in normal adult men.
Talbot JA; Rodger RS; Shalet SM; Littley MD; Robertson WR
Acta Endocrinol (Copenh); 1990 May; 122(5):643-50. PubMed ID: 2112817
[TBL] [Abstract][Full Text] [Related]
5. Age related changes in the pituitary-testicular axis in normal men; lower serum testosterone results from decreased bioactive LH drive.
Mitchell R; Hollis S; Rothwell C; Robertson WR
Clin Endocrinol (Oxf); 1995 May; 42(5):501-7. PubMed ID: 7621569
[TBL] [Abstract][Full Text] [Related]
6. Serum bioactive and immunoreactive follicle-stimulating hormone in prostatic cancer patients during gonadotropin-releasing hormone agonist treatment and after orchidectomy.
Huhtaniemi IT; Dahl KD; Rannikko S; Hsueh AJ
J Clin Endocrinol Metab; 1988 Feb; 66(2):308-13. PubMed ID: 3123510
[TBL] [Abstract][Full Text] [Related]
7. Semen quality and reproductive hormones before orchiectomy in men with testicular cancer.
Petersen PM; Skakkebaek NE; Vistisen K; Rørth M; Giwercman A
J Clin Oncol; 1999 Mar; 17(3):941-7. PubMed ID: 10071288
[TBL] [Abstract][Full Text] [Related]
8. Testosterone reduces the bioactivity of luteinizing hormone (LH) in man.
Tsatsoulis A; Shalet SM; Richardson P; Robertson WR
Clin Endocrinol (Oxf); 1990 Jan; 32(1):73-82. PubMed ID: 2110048
[TBL] [Abstract][Full Text] [Related]
9. Quantitative and qualitative changes in LH secretion following pulsatile GnRH therapy in a man with idiopathic hypogonadotrophic hypogonadism.
Tsatsoulis A; Shalet SM; Talbot A; Robertson WR
Clin Endocrinol (Oxf); 1989 Feb; 30(2):167-75. PubMed ID: 2692879
[TBL] [Abstract][Full Text] [Related]
10. Low serum bioactive luteinizing hormone in nonorganic male impotence: possible relationship with altered gonadotropin-releasing hormone pulsatility.
Fabbri A; Jannini EA; Ulisse S; Gnessi L; Moretti C; Frajese G; Isidori A
J Clin Endocrinol Metab; 1988 Nov; 67(5):867-75. PubMed ID: 3141450
[TBL] [Abstract][Full Text] [Related]
11. Immunoactive inhibin as a marker of Sertoli cell function following cytotoxic damage to the human testis.
Tsatsoulis A; Shalet SM; Morris ID; de Kretser DM
Horm Res; 1990; 34(5-6):254-9. PubMed ID: 2129227
[TBL] [Abstract][Full Text] [Related]
12. The effects of aging in normal men on bioavailable testosterone and luteinizing hormone secretion: response to clomiphene citrate.
Tenover JS; Matsumoto AM; Plymate SR; Bremner WJ
J Clin Endocrinol Metab; 1987 Dec; 65(6):1118-26. PubMed ID: 3119649
[TBL] [Abstract][Full Text] [Related]
13. Luteinizing hormone regulation by sex steroids in men with germinal and Leydig cell tumours.
Reznik Y; Rieu M; Kuhn JM; Mandard JC; Bottet P; Lemonnier D; Bekka S; Mahoudeau J
Clin Endocrinol (Oxf); 1993 May; 38(5):487-93. PubMed ID: 8392454
[TBL] [Abstract][Full Text] [Related]
14. Effects of human recombinant luteinizing hormone and follicle-stimulating hormone in patients with acquired hypogonadotropic hypogonadism: study of Sertoli and Leydig cell secretions and interactions.
Young J; Couzinet B; Chanson P; Brailly S; Loumaye E; Schaison G
J Clin Endocrinol Metab; 2000 Sep; 85(9):3239-44. PubMed ID: 10999815
[TBL] [Abstract][Full Text] [Related]
15. Pattern of secretion of bioactive and immunoreactive gonadotrophins in normal pubertal children.
Dunger DB; Villa AK; Matthews DR; Edge JA; Jones J; Rothwell C; Preece MA; Robertson WR
Clin Endocrinol (Oxf); 1991 Sep; 35(3):267-75. PubMed ID: 1742886
[TBL] [Abstract][Full Text] [Related]
16. The pituitary-Leydig cell axis in men with severe damage to the germinal epithelium.
Tsatsoulis A; Whitehead E; St John J; Shalet SM; Robertson WR
Clin Endocrinol (Oxf); 1987 Dec; 27(6):683-9. PubMed ID: 3138051
[TBL] [Abstract][Full Text] [Related]
17. Possible involvement of inhibin in altered follicle-stimulating hormone (FSH) secretion during dissociated luteinizing hormone (LH) and FSH release: unilateral castration and experimental cryptorchidism.
Rivier C; Meunier H; Roberts V; Vale W
Biol Reprod; 1989 Nov; 41(5):967-81. PubMed ID: 2483127
[TBL] [Abstract][Full Text] [Related]
18. A preponderance of circulating basic isoforms is associated with decreased plasma half-life and biological to immunological ratio of gonadotropin-releasing hormone-releasable luteinizing hormone in obese men.
Castro-Fernández C; Olivares A; Söderlund D; López-Alvarenga JC; Zambrano E; Veldhuis JD; Ulloa-Aguirre A; Méndez JP
J Clin Endocrinol Metab; 2000 Dec; 85(12):4603-10. PubMed ID: 11134115
[TBL] [Abstract][Full Text] [Related]
19. Testicular function after radioiodine therapy for thyroid carcinoma.
Wichers M; Benz E; Palmedo H; Biersack HJ; Grünwald F; Klingmüller D
Eur J Nucl Med; 2000 May; 27(5):503-7. PubMed ID: 10853804
[TBL] [Abstract][Full Text] [Related]
20. Pulsatile bioactive luteinizing hormone secretion in men with chronic renal failure and following renal transplantation.
Talbot JA; Rodger RS; Robertson WR
Nephron; 1990; 56(1):66-72. PubMed ID: 2122267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
